Erratum to: Monocyte CD169 Expression as a Biomarker in the Early Diagnosis of Coronavirus Disease 2019

Archive ouverte

Bedin, Anne-Sophie | Makinson, Alain | Picot, Marie-Christine | Mennechet, Frank | Malergue, Fabrice | Pisoni, Amandine | Nyiramigisha, Esperance | Montagnier, Lise | Bollore, Karine | Debiesse, Ségolène | Morquin, David | Bourgoin, Pénélope | Veyrenche, Nicolas | Renault, Constance | Foulongne, Vincent | Bret, Caroline | Bourdin, Arnaud | Le Moing, Vincent | van de Perre, Philippe | Tuaillon, Edouard

Edité par CCSD ; Oxford University Press -

International audience. Abstract We assessed the expression of CD169, a type I interferon-inducible receptor, on monocytes (monocyte CD169 [mCD169]) in 53 adult patients admitted to the hospital during the coronavirus disease 2019 (COVID-19) outbreak for a suspicion of severe acute respiratory syndrome coronavirus 2 infection. Monocyte CD169 was strongly overexpressed in 30 of 32 (93.7%) confirmed COVID-19 cases, compared with 3 of 21 (14.3%) patients in whom the diagnosis of COVID-19 was finally ruled out. Monocyte CD169 was associated with the plasma interferon-alpha level and thrombocytopenia. Monocyte CD169 testing may be helpful for the rapid triage of suspected COVID-19 patients during an outbreak.

• Description
• Sujet/Public
• Outil
• Outil d'anticipation
• Mémoire et thèse
• Gestion